The Boston-based digital pathology firm's updated US Food and Drug Administration clearance will help it to quickly validate its software with new hardware combinations.

Premier Medical owner and CEO Kevin Murdock paid kickbacks for cancer genetic testing referrals, defrauding Georgia, Colorado, and South Carolina Medicaid, DOJ said.

The company also offers platform-agnostic next-generation sequencing tests and a suite of sample prep and thermal cycling instruments.

The firm saw growth in its core laboratory segment but declines in molecular, point of care, and rapid diagnostics.

The agency said that the test is unnecessary for the screening of whole blood and blood components that are screened with nucleic acid tests and core antigen tests.

The company's next-generation sequencing-based test is used to aid the detection of cancers in patients with indeterminate ...

Last week, readers were most interested in a story about an extended collaboration between Personalis and Tempus to include colorectal cancer.

The partnership will initially focus on low-abundance biomarkers supporting translational research in Alzheimer's disease.

NEW YORK – QuidelOrtho announced Monday an integration deal making fecal biomarker testing from Bühlmann Laboratories available on QuidelOrtho's Vitros system. The Bühlmann fecal tests detect ...

NEW YORK – Phase Scientific said Wednesday that has signed an exclusive US distribution agreement with Lumos Diagnostics for a 10-minute point-of-care blood test to distinguish bacterial and ...